The risk of cardiovascular events following treatment for psoriatic arthritis with a biological agent
bDMARDs may reduce cardiovascular events and mortality in PsA, but infection risks warrant close monitoring. Further research is needed to refine treatment strategies.
Authors
- Yu‐Jih Su (ORCID: https://orcid.org/0000-0002-7274-3458)
- Tien‐Ming Chan (ORCID: https://orcid.org/0000-0002-0753-4529)
- Shang-Hong Lin
- Lin Yuan (ORCID: https://orcid.org/0000-0002-4887-2647)
- Ming‐Lung Tsai (ORCID: https://orcid.org/0000-0002-4199-713X)
- Chung-Yuan Hsu
- Tien-Hsing Chen
- Ning‐I Yang (ORCID: https://orcid.org/0000-0002-0721-1332)
Institutions
- Chang Gung University of Science and Technology (TW)
- National Sun Yat-sen University (TW)
- Chang Gung University (TW)
- Taipei Municipal YangMing Hospital (TW)
- Kaohsiung Chang Gung Memorial Hospital (TW)
- Keelung Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1093/rheumatology/keaf487
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00